Aberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activity

Overview of attention for article published in Arthritis Research & Therapy, May 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 61 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

ANTI-CD200R1 ANTIBODIES

Application WO-2023222068-A1

World Intellectual Property Organisation (WIPO)

CD200 mutants and its uses

Grant US-11203628-B2

United States of America

CD200 INHIBITORS AND METHODS OF USE THEREOF

Application WO-2017079335-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.